These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11826612)
21. Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism. Volonté MA; Perani D; Lanzi R; Poggi A; Anchisi D; Balini A; Comi G; Fazio F J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):691-5. PubMed ID: 11606688 [TBL] [Abstract][Full Text] [Related]
22. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Volkow ND; Fowler JS; Wolf AP; Hitzemann R; Dewey S; Bendriem B; Alpert R; Hoff A Am J Psychiatry; 1991 May; 148(5):621-6. PubMed ID: 2018164 [TBL] [Abstract][Full Text] [Related]
23. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333 [TBL] [Abstract][Full Text] [Related]
24. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958 [TBL] [Abstract][Full Text] [Related]
25. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470 [TBL] [Abstract][Full Text] [Related]
26. Reversible striatal hypermetabolism in a case of Sydenham's chorea. Goldman S; Amrom D; Szliwowski HB; Detemmerman D; Goldman S; Bidaut LM; Stanus E; Luxen A Mov Disord; 1993 Jul; 8(3):355-8. PubMed ID: 8341301 [TBL] [Abstract][Full Text] [Related]
27. Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study. Bouilleret V; Semah F; Chassoux F; Mantzaridez M; Biraben A; Trebossen R; Ribeiro MJ Neurology; 2008 Jan; 70(3):177-84. PubMed ID: 18195263 [TBL] [Abstract][Full Text] [Related]
28. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590 [TBL] [Abstract][Full Text] [Related]
30. Neural networks: neural systems vi: basal ganglia. Tamminga C; Holcomb H Am J Psychiatry; 2001 Feb; 158(2):185. PubMed ID: 11156797 [No Abstract] [Full Text] [Related]
31. PET imaging in epilepsy: basal ganglia and thalamic involvement. Semah F Epileptic Disord; 2002 Dec; 4 Suppl 3():S55-60. PubMed ID: 12495875 [TBL] [Abstract][Full Text] [Related]
32. Gilles de la tourette syndrome: studies with the fluorine-18-labeled fluorodeoxyglucose positron emission tomographic method. Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Kessler R; Di Chiro G Ann Neurol; 1984; 15 Suppl():S175. PubMed ID: 6611119 [No Abstract] [Full Text] [Related]
33. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. Laureys S; Salmon E; Garraux G; Peigneux P; Lemaire C; Degueldre C; Franck G J Neurol; 1999 Dec; 246(12):1151-8. PubMed ID: 10653307 [TBL] [Abstract][Full Text] [Related]
34. Acute effects of thalamotomy and pallidotomy on regional cerebral metabolism, evaluated by PET. Henselmans JM; de Jong BM; Pruim J; Staal MJ; Rutgers AW; Haaxma R Clin Neurol Neurosurg; 2000 Jun; 102(2):84-90. PubMed ID: 10817894 [TBL] [Abstract][Full Text] [Related]
35. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis. Calming U; Bemstrand C; Mosskin M; Elander SS; Ingvar M; Henter JI J Pediatr; 2002 Sep; 141(3):435-40. PubMed ID: 12219070 [TBL] [Abstract][Full Text] [Related]
36. Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome. Przedborski S; Goldman S; Levivier M; Giladi N; Bidaut LM; Hildebrand J; Stanus E; Labar D; Luxen A Mov Disord; 1993 Jul; 8(3):391-5. PubMed ID: 8341311 [TBL] [Abstract][Full Text] [Related]
37. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism. Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341 [TBL] [Abstract][Full Text] [Related]
38. [Brain PET-FDG evolutive control of a metastatic pinealoblastoma]. Gil Martínez EM; Ramírez López MA; Moya García F; González Cabezas P Rev Esp Med Nucl; 2006; 25(1):40. PubMed ID: 16540011 [No Abstract] [Full Text] [Related]
39. Neuroimaging on delayed postanoxic encephalopathy with lesions localized in basal ganglia. Takahashi W; Ohnuki Y; Takizawa S; Yoshii F; Takagi S; Kamei T; Shinohara Y Clin Imaging; 1998; 22(3):188-91. PubMed ID: 9559230 [TBL] [Abstract][Full Text] [Related]
40. Increased brain glucose metabolism in chronic severe traumatic brain injury as determined by longitudinal 18F-FDG PET/CT. Yamaki T; Uchino Y; Henmi H; Kamezawa M; Hayakawa M; Uchida T; Ozaki Y; Onodera S; Oka N; Odaki M; Itou D; Kobayashi S J Clin Neurosci; 2018 Nov; 57():20-25. PubMed ID: 30172638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]